Drugs / DIAB-PHC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07279909 | Mar 2024 → Aug 2025 overdue | type 2 diabetes mellitus | Hamdard University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DIAB-PHC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07279909 ↗ |
| Route | Oral | “Capsules were given TID with meals to the patients” NCT07279909 ↗ |